Digital Therapeutics Market | Teladoc Health, Omada Health, Welldoc, mySugr GmbH
Gain Full Insights @ https://www.kingsresearch.com/....digital-therapeutics
In May 2024, Otsuka Pharmaceutical launched a new subsidiary to commercialize its digital therapeutic, Rejoyn, and expand its presence in digital therapeutics and connected health products. Rejoyn, developed in partnership with Click Therapeutics, received FDA clearance in April 2024 as the first prescription digital therapeutic for major depressive disorder.
Like
Comment
Share
